# CORolla™ TAA for Heart Failure and Preserved Ejection Fraction and Diastolic Dysfunction

> **NCT01956526** · NA · UNKNOWN · sponsor: **CorAssist Cadiovascular Ltd.** · enrollment: 12 (estimated)

## Conditions studied

- Diastolic Heart Failure NYHA Class III-IV
- Diastolic Dysfunction Secondary to Aortic Stenosis

## Interventions

- **DEVICE:** CORolla™ TAA device

## Key facts

- **NCT ID:** NCT01956526
- **Lead sponsor:** CorAssist Cadiovascular Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2015-09
- **Final completion:** 2017-09
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2013-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01956526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01956526, "CORolla™ TAA for Heart Failure and Preserved Ejection Fraction and Diastolic Dysfunction". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01956526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*